Mission: Impossible - Final Reckoning is the perfect summer blockbuster, with plenty of action and a high-stakes plot, as well as some nostalgia thrown in. Find out what’s new this week on ...

This weekend will be a big one with not one, but two blockbusters opening in theaters, as well as several other films – there’s something for everyone. Mission: Impossible vs Lilo & Stitch ...

Fox News senior strategic analyst Gen. Jack Keane (ret.) argues Iran wants to delay negotiations and drag them out for as long as possible and discusses another Chinese student being arrested for ...

A Long Island speech pathologist said a pioneering bio implant stopped her “horrific” rheumatoid arthritis in its tracks. Massapequa’s Dawn Steiner, 58, said even a simple handshake would ...

May 14, 2025 (GLOBE NEWSWIRE) -- Therini Bio, Inc., a clinical-stage biotech company developing fibrin-targeting immunotherapies for neurodegenerative diseases driven by vascular dysfunction today ...

The NFL has an impressive starting lineup to officially kick off the action, with the Louisiana-born singer Ledisi set to perform the historically significant Black national anthem. Ledisi will ...

For investors in gene therapy biotech bluebird bio, a wait-and-see approach toward a proposed acquisition has paid off. In a revised merger agreement, Carlyle and SK Capital Partners are now ...

Ledisi loved the concept so much, she dedicated an exclusive song to the project, "Real Woman," that summed up the feeling, inspiration and reality. Check out the exclusive video here ...

May 14 (Reuters) - Carlyle Group (CG.O), opens new tab and SK Capital Partners increased their upfront offer to take over gene therapy maker bluebird bio (BLUE.O), opens new tab, the companies ...

The Peace Center will host a performance by Ledisi on June 25 at 7:30 p.m. It will be part of her "Love You Too" tour, and she will be accompanied by Marsha Ambrosius. The Band of Horses ...

Spearhead Bio founder and chief science officer Keith Slotkin stands in a greenhouse. Slotkin's company is spinning out of research he's performed as a principal investigator at the Donald Danforth ...